ACUR - Acura Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue4,4648,587751
Cost of Revenue451656227
Gross Profit4,0137,931524
Operating Expenses
Research Development4,0282,6084,582
Selling General and Administrative6,5168,9947,940
Non Recurring26330201
Total Operating Expenses---
Operating Income or Loss-6,557-4,001-12,199
Income from Continuing Operations
Total Other Income/Expenses Net62169202
Earnings Before Interest and Taxes-6,495-3,832-11,997
Interest Expense8931,1571,212
Income Before Tax-7,388-4,989-13,209
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-7,388-4,989-13,209
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,388-4,989-13,209
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,388-4,989-13,209